Correlation Between Eagle Pharmaceuticals and Kala Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Eagle Pharmaceuticals and Kala Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eagle Pharmaceuticals and Kala Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eagle Pharmaceuticals and Kala Pharmaceuticals, you can compare the effects of market volatilities on Eagle Pharmaceuticals and Kala Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eagle Pharmaceuticals with a short position of Kala Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eagle Pharmaceuticals and Kala Pharmaceuticals.
Diversification Opportunities for Eagle Pharmaceuticals and Kala Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Eagle and Kala is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Eagle Pharmaceuticals and Kala Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kala Pharmaceuticals and Eagle Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eagle Pharmaceuticals are associated (or correlated) with Kala Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kala Pharmaceuticals has no effect on the direction of Eagle Pharmaceuticals i.e., Eagle Pharmaceuticals and Kala Pharmaceuticals go up and down completely randomly.
Pair Corralation between Eagle Pharmaceuticals and Kala Pharmaceuticals
If you would invest 698.00 in Kala Pharmaceuticals on December 27, 2024 and sell it today you would lose (41.00) from holding Kala Pharmaceuticals or give up 5.87% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Eagle Pharmaceuticals vs. Kala Pharmaceuticals
Performance |
Timeline |
Eagle Pharmaceuticals |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Kala Pharmaceuticals |
Eagle Pharmaceuticals and Kala Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Eagle Pharmaceuticals and Kala Pharmaceuticals
The main advantage of trading using opposite Eagle Pharmaceuticals and Kala Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eagle Pharmaceuticals position performs unexpectedly, Kala Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kala Pharmaceuticals will offset losses from the drop in Kala Pharmaceuticals' long position.Eagle Pharmaceuticals vs. ANI Pharmaceuticals | Eagle Pharmaceuticals vs. Phibro Animal Health | Eagle Pharmaceuticals vs. Prestige Brand Holdings | Eagle Pharmaceuticals vs. Collegium Pharmaceutical |
Kala Pharmaceuticals vs. Lifecore Biomedical | Kala Pharmaceuticals vs. Shuttle Pharmaceuticals | Kala Pharmaceuticals vs. Journey Medical Corp | Kala Pharmaceuticals vs. Akanda Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |